Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 456

1.

Injection and Heterosexual Risk Behaviors for HIV Infection Among Non-gay Identifying Men Who Have Sex with Men and Women.

Arasteh K, Des Jarlais DC, McKnight C, Feelemyer J.

AIDS Behav. 2019 Jun 1. doi: 10.1007/s10461-019-02551-3. [Epub ahead of print]

PMID:
31154560
2.

Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Population and Fertility Collaborators.

Lancet. 2018 Nov 10;392(10159):1995-2051. doi: 10.1016/S0140-6736(18)32278-5. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

4.
5.
6.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Mortality Collaborators.

Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

7.

Place-based predictors of HIV viral suppression and durable suppression among heterosexuals in New York city.

Jefferson KA, Kersanske LS, Wolfe ME, Braunstein SL, Haardörfer R, Des Jarlais DC, Campbell ANC, Cooper HL.

AIDS Care. 2019 Jul;31(7):864-874. doi: 10.1080/09540121.2018.1545989. Epub 2018 Nov 26.

PMID:
30477307
9.

Commentary on Grebely et al. (2019): Ending HCV epidemics among people who inject drugs.

Des Jarlais DC.

Addiction. 2019 Jan;114(1):167-168. doi: 10.1111/add.14427. Epub 2018 Sep 23. No abstract available.

PMID:
30246384
10.

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.

Des Jarlais DC, Arasteh K, Feelemyer J, McKnight C, Barnes DM, Perlman DC, Uuskula A, Cooper HLF, Tross S.

Drug Alcohol Depend. 2018 Nov 1;192:74-79. doi: 10.1016/j.drugalcdep.2018.07.034. Epub 2018 Sep 12.

PMID:
30243142
11.
13.

Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Alcohol Collaborators.

Lancet. 2018 Sep 22;392(10152):1015-1035. doi: 10.1016/S0140-6736(18)31310-2. Epub 2018 Aug 23. Review. Erratum in: Lancet. 2018 Sep 29;392(10153):1116. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

14.

Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.

Behrends CN, Nugent AV, Des Jarlais DC, Frimpong JA, Perlman DC, Schackman BR.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):e76-e78. doi: 10.1097/QAI.0000000000001792. No abstract available.

PMID:
29985266
15.

Identifying Which Place Characteristics are Associated with the Odds of Recent HIV Testing in a Large Sample of People Who Inject Drugs in 19 US Metropolitan Areas.

Tempalski B, Cooper HLF, Kelley ME, Linton SL, Wolfe ME, Chen YT, Ross Z, Des Jarlais DC, Friedman SR, Williams LD, Semaan S, DiNenno E, Wejnert C, Broz D, Paz-Bailey G; National HIV Behavioral Surveillance Study Group.

AIDS Behav. 2019 Feb;23(2):318-335. doi: 10.1007/s10461-018-2217-z.

PMID:
29971735
16.

Working With Persons Who Inject Drugs and Live in Rural Areas: Implications From China/Vietnam for the USA.

Des Jarlais DC, Hammett TM, Kieu B, Chen Y, Feelemyer J.

Curr HIV/AIDS Rep. 2018 Aug;15(4):302-307. doi: 10.1007/s11904-018-0405-0. Review.

PMID:
29948610
17.

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.

GBD 2016 Healthcare Access and Quality Collaborators.

Lancet. 2018 Jun 2;391(10136):2236-2271. doi: 10.1016/S0140-6736(18)30994-2. Epub 2018 Jun 1.

18.

Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia.

Uusküla A, Barnes DM, Raag M, Talu A, Tross S, Des Jarlais DC.

Drug Alcohol Depend. 2018 Jul 1;188:64-70. doi: 10.1016/j.drugalcdep.2018.03.048. Epub 2018 May 8.

PMID:
29754028
19.

Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in Athens, Greece.

Paraskevis D, Nikolopoulos GK, Sypsa V, Psichogiou M, Pantavou K, Kostaki E, Karamitros T, Paraskeva D, Schneider J, Malliori M, Friedman SR, Des Jarlais DC, Daikos GL, Hatzakis A.

Infect Genet Evol. 2018 Aug;62:11-16. doi: 10.1016/j.meegid.2018.04.010. Epub 2018 Apr 10.

PMID:
29653216
20.

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.

Des Jarlais DC, Cooper HLF, Arasteh K, Feelemyer J, McKnight C, Ross Z.

PLoS One. 2018 Mar 29;13(3):e0194799. doi: 10.1371/journal.pone.0194799. eCollection 2018.

Supplemental Content

Loading ...
Support Center